Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Thomas Dirschka, Girish Gupta, Giuseppe Micali, Eggert Stockfleth, Nicole Basset-Séguin, Véronique Del Marmol, Reinhard Dummer, Gregor B. E. Jemec, Josep Malvehy, Ketty Peris, Susana Puig, Alexander J. Stratigos, Iris Zalaudek & Giovanni Pellacani. (2017) Real-world approach to actinic keratosis management: practical treatment algorithm for office-based dermatology. Journal of Dermatological Treatment 28:5, pages 431-442.
Read now
Read now
Christopher G Nelson. (2011) Diclofenac gel in the treatment of actinic keratoses. Therapeutics and Clinical Risk Management 7, pages 207-211.
Read now
Read now
Articles from other publishers (20)
María Reyes García de la Fuente, Álvaro Rico Morales & Josep Manel Casanova Seuma. (2023) Lesiones premalignas de piel y mucosas y carcinoma escamoso in situ. FMC - Formación Médica Continuada en Atención Primaria 30:3, pages 14-27.
Crossref
Crossref
Navami Prabhakar Koyande, Rupali Srivastava, Ananya Padmakumar & Aravind Kumar Rengan. (2022) Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review. Vaccines 10:10, pages 1727.
Crossref
Crossref
Mahsa Keshavarz-Fathi & Nima Rezaei. (2021) Cancer Immunoprevention: Current Status and Future Directions. Archivum Immunologiae et Therapiae Experimentalis 69:1.
Crossref
Crossref
Claudio Conforti, Roberta Giuffrida, Caterina Dianzani, Fabrizio Guarneri, Giovanni Francesco Marangi, Nicoleta Neagu, Paolo Persichetti, Iris Zalaudek & Nicola di Meo. (2021)
Effectiveness and tolerability of treatment for isolated actinic keratoses: A retrospective comparison between cryotherapy, CO
2
laser and 5‐fluorouracil 0.5%/salicylic acid 10%
. Dermatologic Therapy 34:2.
Crossref
Crossref
Ömer Faruk Dilek, Fuat Uslusoy & Mustafa Asım Aydın. 2021. Prophylactic Surgery. Prophylactic Surgery
325
358
.
Marco Michelini. (2020) Photodynamic therapy activated by intense pulsed light in the treatment of actinic keratosis. Giornale Italiano di Dermatologia e Venereologia 155:4.
Crossref
Crossref
Caterina Dianzani, Claudio Conforti, Roberta Giuffrida, Paola Corneli, Nicola Meo, Eleonora Farinazzo, Anna Moret, Giovanni Magaton Rizzi & Iris Zalaudek. (2020) Current therapies for actinic keratosis. International Journal of Dermatology 59:6, pages 677-684.
Crossref
Crossref
Elisa Robustelli Test, Giuseppe Fumo, Marialuisa Corbeddu, Caterina Ferreli & Franco Rongioletti. (2020) Efficacy of Imiquimod 3.75% for the treatment of extensive Bowen's disease of the face in an elderly patient. Dermatologic Therapy 33:2.
Crossref
Crossref
Duygu Gülseren, Gonca Elçin & Yahya Büyükaşık. (2019) Severe cytopenia related with the concomitant use of imiquimod and hydroxyurea. Dermatologic Therapy 32:6.
Crossref
Crossref
Angeliki Befon, Vassiliki Tzanetakou, Antonios Panagiotopoulos, Vasiliki Chasapi, Christina Antoniou & Alexander J. Stratigos. (2019) Imiquimod 3.75% for field‐directed therapy of actinic keratosis: results of a prospective case‐series study in Greece. International Journal of Dermatology 58:9, pages 1040-1044.
Crossref
Crossref
Harald P. M. Gollnick. (2017) Die Prävention und Therapie Aktinischer KeratosenPrevention and therapy of actinic keratoses. MMW - Fortschritte der Medizin 159:8, pages 60-68.
Crossref
Crossref
G. Gupta. (2015) Lmax and imiquimod 3.75% in daily clinical practice. Journal of the European Academy of Dermatology and Venereology 29, pages 15-18.
Crossref
Crossref
E. Stockfleth. (2015) Lmax and imiquimod 3.75%: the new standard in AK management. Journal of the European Academy of Dermatology and Venereology 29, pages 9-14.
Crossref
Crossref
Paola Pasquali. 2015. Cryosurgery. Cryosurgery
193
212
.
Noriko Tanaka, Chika Ohata, Norito Ishii, Kazuko Imamura, Akihiro Ueda, Minao Furumura, Shinichiro Yasumoto, Tamihiro Kawakami, Daisuke Tsuruta & Takashi Hashimoto. (2013) Comparative study for the effect of photodynamic therapy, imiquimod immunotherapy and combination of both therapies on 40 lesions of actinic keratosis in Japanese patients. The Journal of Dermatology 40:12, pages 962-967.
Crossref
Crossref
Miquel Ribera Pibernat & Natalia Fernández-Chico. (2013) Tratamiento de las queratosis actínicas. FMC - Formación Médica Continuada en Atención Primaria 20:10, pages 592-601.
Crossref
Crossref
Nasreen Ghuznavi, Nadia F Nocera, Andrew R Guajardo & Jeffrey M Weinberg. (2012) Emerging medical treatments for actinic keratoses, squamous cell carcinoma and basal cell carcinoma. Clinical Investigation 2:9, pages 909-921.
Crossref
Crossref
Stephanie R. Johnson & Melissa A. Taylor. (2012) Identification and Management of Malignant Skin Lesions Among Older Adults. The Journal for Nurse Practitioners 8:8, pages 610-616.
Crossref
Crossref
Steven M. Couch & Philip L. Custer. (2012) Topical 5-Fluorouracil for the Treatment of Periocular Actinic Keratosis and Low-Grade Squamous Malignancy. Ophthalmic Plastic & Reconstructive Surgery 28:3, pages 181-183.
Crossref
Crossref
M. Schlaak, W. von Bartenwerffer & C. Mauch. (2011) Medikamentöse Therapie nichtmelanozytärer epithelialer TumoreCurrent therapy of non-melanoma skin cancer. Der Hautarzt 62:6, pages 430-435.
Crossref
Crossref